accutase drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (6)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition. (2025)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- A Compendium of Mutational Signatures of Environmental Agents. (2019)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| accutase | drug | 25 | 47 |
| accutase (stem cell technologies) | drug | — | — |
| accutase (thermo fisher scientific) | drug | — | — |
| accutase™ | drug | — | — |
| innovative cell technologies, cat. no. at-104 | drug | — | — |
| sigma #a6964 | drug | — | — |